CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 651 - 660 of 740
Study Number Lead Group Study Title CIRB Study Status
S1513 SWOG Randomized Phase II Study of 2nd Line FOLFIRI Versus Modified FOLFIRI with PARP Inhibitor ABT-888 (Veliparib) (NSC-737664) in Metastatic Pancreatic Cancer Adult CIRB - Late Phase Emphasis Available to Open
S1406 SWOG Randomized Phase II Study of Irinotecan and Cetuximab with or without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer Adult CIRB - Early Phase Emphasis Available to Open
A091401 Alliance Randomized Phase II Study Of Nivolumab With Or Without Ipilimumab In Patients With Metastatic Or Unresectable Sarcoma Adult CIRB - Late Phase Emphasis Available to Open
EA2142 ECOG-ACRIN Randomized Phase II Study of Platinum and Etoposide versus Temozolomide and Capecitabine in Patients with Advanced G3 Non-Small Cell Gastroenteropancreatic Neuroendocrine Carcinomas Adult CIRB - Early Phase Emphasis Available to Open
9706 ETCTN Randomized phase II study to assess the role of Nivolumab as single agent to eliminate minimal residual disease and maintain remission in acute myelogenous leukemia (AML) patients after chemotherapy (REMAIN Trial) Adult CIRB - Early Phase Emphasis Available to Open
A221208 Alliance Randomized Phase II Study: Corticosteroids and Bevacizumab vs. Corticosteroids and Placebo (BeSt) for Radionecrosis after Radiosurgery for Brain Metastases Cancer Prevention and Control CIRB Available to Open
S1608 SWOG Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma Adult CIRB - Late Phase Emphasis Available to Open
NRG-LU001 NRG Randomized Phase II Trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLC Adult CIRB - Late Phase Emphasis Available to Open
NRG-BN001 NRG Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Adult CIRB - Late Phase Emphasis Available to Open
NRG-GU007 NRG Randomized Phase II Trial of Niraparib with Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (with Initial Phase I) Adult CIRB - Late Phase Emphasis Available to Open
Displaying 651 - 660 of 740